Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study

• Päätekijät: Ki Hwan Kim (Tekijä), Chun Soo Kim (Tekijä), Hwang Min Kim (Tekijä), Jong-Duck Kim (Tekijä), Sang Hyuk Ma (Tekijä), Dong Ho Kim (Tekijä), Pyoung-Han Hwang (Tekijä), Ji-Whan Han (Tekijä), Taek-Jin Lee (Tekijä), Joon Hyung Kim (Tekijä), Naveen Karkada (Tekijä), Narcisa Mesaros (Tekijä), Woo-Yun Sohn (Tekijä), Jong-Hyun Kim (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Taylor & Francis Group, 2019-02-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

We assessed the immunogenicity and safety of a three-dose primary vaccination schedule with the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in Korean infants. In this phase III open-label, multicenter study (NCT01309646)...